Search

everythinglearnresearchcommunity

for

Search:↓

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

JAK inhibitors show promise for treating various skin diseases.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Microneedle patches could replace injections but need more development for better use in medicine.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Improving drug delivery through the skin requires understanding skin and using enhancers.

More research is needed to understand and treat morphea effectively.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

GLPLS and LPP are variants of lichen planus.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Alopecia areata affects 1.45% of people in Japan, impacting mood and self-esteem, with many not seeking treatment.

Regenerative treatments for vitiligo show promise but need more research for long-term safety and effectiveness.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Sodium alginate-based hydrogels are promising for medical use due to their versatility and biocompatibility.

Exosomes and cell culture-conditioned media improve skin quality and reduce aging signs.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Activating Tgr5 may help treat hair loss and bone loss.

Exosomes show promise in skin and hair treatments, but more research is needed to ensure their safety and effectiveness.

IBD treatment is complex and requires personalized approaches due to varying patient responses.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Blocking certain immune signals can reduce skin damage from radiation therapy.